baber/WOPTO huggingface dataset:
Patent ZA-200109266-B (ZA)
Title: Safety visor.
Inventor: FOLKESSON JAN
IPC: A42B3/22
Filed: 2001-11-09
Abstract: A safety visor is produced by etching of metal and a grid that defines a large number of light-permeating holes. The safety visor has at least two zones where the holes are of different areas and/or configuration. An upper central zone has greater light transmission than the remaining zones of the safety visor. The C-C spacing for the hole is constant in both the vertical and lateral directions regardless of in which region of the safety visor the holes are located. In one preferred embodiment, the holes are hexagonal with two approximately parallel sides that are longer than the remaining sides and are directed in the vertical direction of the safety visor.
Patent ZA-200207933-B (ZA)
Title: Stabilized pharmaceutical compositions containing calcium channel blockers.
Inventor: WAKIYAMA NAOKI
IPC: A61K31/444
Filed: 2002-10-02
Abstract: The present invention provides a pharmaceutical composition containing a calcium blocker of the following formula or a pharmacologically acceptable salt thereof and a pharmacologically acceptable alkaline material which is added to an extent such that an aqueous solution or dispersion solution of said pharmaceutical composition containing a calcium blocker has a pH of at least 8: <CHEM> Äwherein R<1> represents an optionally substituted C1-C4 alkyl group, an amino group or a cyano group; R<2> represents an optionally substituted C1-C4 alkyl group, a substituted C3-C4 alkenyl group, or a substituted 4- to 6-membered cyclic amino group; R<3> represents a substituted phenyl group; R<4> represents an optionally substituted C1-C4 alkoxycarbonyl group, a 1,3,2-phosphorinan-2-yl group, or a 5,5-dimethyl-1,3,2-phosphorinan-2-yl group, R<5> represents a C1-C4 alkyl groupÜ.
Patent ZA-200410050-B (ZA)
Title: Antiperspirant aerosol compositions
Inventor: BROWN NATHAN C
IPC: A61K/
Filed: 2004-12-13
Abstract: A suspension antiperspirant aerosol composition comprising milled activated aluminium chlorohydrate (AACH) having non-hollow particles and a carrier fluid comprising a masking oil of viscosity 10<SUP>3 </SUP>mm<SUP>2</SUP>/s or greater gives good antiperspirancey and reduced levels of white deposits.
Patent ZA-200504981-B (ZA)
Title: Method and device for applying a textile auxilary during the stich-bonding of geotextiles involving a hydrodynamics stitch-bonding process
Inventor: BORNMANN UWE
IPC: D04H3/007
Filed: 2003-11-26
Abstract: The auxiliary medium is dosed directly into the fluid used for hydrodynamic consolidation.  An Independent claim is included for the corresponding geotextile.
Patent ZA-200607745-B (ZA)
Title: Electric energy generating modules with a two-dimensional profile and method of fabricating the same
Inventor: DIEGO FISCHER
IPC: H01L31/042
Filed: 2005-03-16
Abstract: An electric energy generating module is shaped to take on a desired two dimensional profile to match a non-flat surface or architectural element such as corrugated roofing. The module includes an electric energy generating film sealed between a top layer of encapsulant material and a bottom layer of encapsulant material. The type and quantity of the encapsulant materials are such that the shape of the encapsulant materials can be altered when a high temperature and/or pressure is applied to the module, but where the encapsulant materials provide a rigid structure around the electric energy generating film under ordinary (i.e., naturally occurring) temperature and pressure conditions. The module can therefore be shaped by applying a suitable pressure and/or a high temperature but, once placed under ordinary temperature and pressure conditions, the module has a rigid structure.
Patent ZA-200705660-B (ZA)
Title: Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate
Inventor: MAYYAS AL-REMAWI
IPC: A61K/
Filed: 2005-12-29
Abstract: The present invention is directed to a controlled-release pharmaceutical composition providing a sustained delivery of the basic drug Terbutaline sulfate, said composition comprising at least Terbutaline sulfate or a derivative thereof as an active agent, and further comprising an inactive matrix, said matrix comprising a hydrophilic polysaccharide polymer mixture, said mixture comprising chitosan or a derivative thereof, and further comprising xanthan gum or a derivative thereof, wherein the ratio of xanthan gum and chitosan within said mixture is in the range from about 1:10 to about 10:1, and said composition optionally comprising sodium bicarbonate.
Patent ZA-201003613-B (ZA)
Title: Drive arrangement with open loop hydraulic mechanism operable as a pump or a motor
Inventor: GRANT NORMAN
Filed: 2010-05-21
Abstract: A drive arrangement suitable for driving a final drive comprises a first drive means and a power-splitting gear arrangement. A first hydraulic mechanism is operable either as a pump or a motor. The first hydraulic mechanism is capable of being driven from the first drive means or from the final drive or both concurrently, acting through the gear arrangement. The final drive is drivable through the gear arrangement from the first drive means or the first hydraulic mechanism or both concurrently.
Patent ZA-202213959-B (ZA)
Title: Validation of procedures in a decontamination process
Inventor: BRAND THOMAS
Filed: 2022-12-22
Abstract: Disclosed is a method for validating a decontamination procedure performed using a decontamination system that comprises a first product for use in a first step of the procedure, such as a pre-clean step, and a second product for use in a subsequent second step of the procedure, such as a disinfection step. The method comprises capturing a video stream of a work area in which the decontamination procedure is carried out by a user, analysing the video stream to identify when the first product is present in the work area and when the second product is present in the work area, determining, based on said identification, that the first and second products have been presented in the correct order in the decontamination procedure, and causing a corresponding indication to be provided to the user. The method may include alerting the user to potential errors and/or logging data to provide an audit trail.
Patent GR-1004610-B (GR)
Title: Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of cancer
Inventor: FOTSIS THEODOROS
IPC: C12N15/861
Filed: 2003-07-25
Abstract: he invention relates to the use of activin A, consstitutively activated ALK-4 or the combination of activin A and ALK-4 for the preparation of a pharmaceutical composition for the treatment of cancer. The invention furthermore relates to pharmaceutical compositions compprising constitutively activated AlK-4 and the combination of activin A and ALK-4, respectively and to vehicless such as virusses for carrying the active ingredients activin A, constitutively activated ALK-4 and the combinationof activin A and ALK-4 and functionally active derivatives if said compounds.
Patent GR-1004843-B (GR)
Title: Method for the manufactrure of transparencies with paper and vegetal material coatings applied to cloth or plastic or glass sub-layers
Inventor: PETROPOULOU ALEXANDRA-AMALIA S
IPC: B32B9/02
Filed: 2003-07-30
Abstract: he invention relates to a method for manufacturing transparencies with paper and vegetal material coatings applied to fabric A, or plastic A, or glass A sub-layers. Said method is composed of: a) an iron, aluminium or wooden base covered with fabric A, or plastic sheet A coated with paper E and vegetal materials alternately glued and translucent due to the glue (
Patent MX-358056-B (MX)
Title: Lancing device.
Inventor: DAVID K BOEHM
IPC: A61B5/15
Filed: 2005-01-12
Abstract: An apparatus and method for lancing a surface provides an adjustable nozzle assembly that includes an interior nozzle, a collar, and an exterior nozzle with a surface that contacts the surface to be lanced. The exterior nozzle can then rotate relative to the interior nozzle and, thereby, vary the lancing depth of a lancet. The apparatus and method for lancing a surface also provides for a rearward body assembly that includes an interior tube, a lancet holder, an internal compression spring, a retainer, a rearward body, and an external compression spring. Longitudinal movement of the rearward body away from the interior tube can compress the interior compression spring and can, thereby, spring load the lancing device. The apparatus and method for assembling the adjustable nozzle assembly of the lancing device provides for an interior nozzle with an assembly groove and a ramped groove separated by a raised boss. The apparatus and method for assembling also provides for a collar with a collar pin for sliding in the assembly groove, over the raised boss, and into the ramped groove.
Patent MX-344247-B (MX)
Title: Responsiveness to angiogenesis inhibitors.
Inventor: FOERNZLER DOROTHEE
IPC: C12Q1/68
Filed: 2010-08-03
Abstract: The present invention relates to methods for improving the overall survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the vascular endothelial growth factor receptor 1 (VEGFR-1) gene. The present invention further provides methods for improving the progression-free survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the VEGFR-1 gene. The present invention also provides for methods for assessing the responsiveness of a patient to an angiogenesis inhibitor by determining the presence of one or more variant alleles of the VEGFR-1 gene. The present invention relates to methods for improving the overall survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the vascular endothelial growth factor receptor 1 (VEGFR-1) gene. The present invention further provides methods for improving the progression-free survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the VEGFR-1 gene. The present invention also provides for methods for assessing the responsiveness of a patient to an angiogenesis inhibitor by determining the presence of one or more variant alleles of the VEGFR-1 gene. The invention relates to a method for determining the clamping force on a mechanical joint connection connecting at least two components by coupling sound waves into the joint connection. The invention is characterized by the combination of the following method steps: exciting the mechanical joint connection in order to generate oscillation, capturing the oscillations made by the joint connection due to the excitement, and analyzing the oscillations of the joint connection on the basis of reference oscillation patterns stored in a reference dataset, a known clamping force prevailing in the joint connection to be tested being associated with each pattern.
Patent MX-346337-B (MX)
Title: Nanopatterned medical device with enhanced cellular interaction.
Inventor: RUSSELL FREDERICK ROSS *
IPC: A61K38/19
Filed: 2011-04-27
Abstract: Disclosed are nanotopography-based methods and devices for interacting with a component of the dermal connective tissue. Devices include structures fabricated on a surface to form a nanotopography. A random or non-random pattern of structures may be fabricated such as a complex pattern including structures of differing sizes and/or shapes. Microneedles may be beneficially utilized for delivery of an agent to a cell or tissue. Devices may be utilized to directly or indirectly alter cell behavior through the interaction of a fabricated nanotopography with the plasma membrane of a cell and/or with an extracellular matrix component.
Patent MX-347981-B (MX)
Title: Pan-her antibody composition.
Inventor: JOHAN LANTTO
IPC: A61K39/395
Filed: 2011-10-31
Abstract: The present invention is directed to improved therapeutics against receptors within the EGFR/ErbB/HER family that more broadly interfere with multiple members of the HER family (pan-HER inhibition). More particularly, the invention is directed to the use of antibody compositions for human cancer therapy. In vitro studies have shown that the antibody compositions of the invention targeting multiple HER family receptors are superior to antibody compositions targeting only one HER family receptor.
Patent MX-354362-B (MX)
Title: Plugging device.
Inventor: ESPEN HIORTH
IPC: E21B33/12
Filed: 2011-11-21
Abstract: The invention relates to a plugging device (1) comprising a packer device (4) for pressure tight sealing of a pipe. The packer device (4) comprises a first outer packer supporting device (20), a second outer packer supporting device (22) and an outer packer body (50) provided axially between the first packer supporting device (20) and the second packer supporting device (22). The outer packer (50) is movable between a radially retracted position and a radially expanded position by an axial movement between the first and second outer packer supporting devices (20, 22). The packer device 4 further comprises a first inner packer supporting device (12), a second inner packer supporting device (14) and an inner packer body (15) provided axially between the first inner packer supporting device (12) and the second inner packer supporting device (14). The inner packer body (15) is provided radially inside the outer packer body (50) when the outer body is in the radially expanded position. The inner packer body (15) is movable between a radially retracted position and a radially expanded position by an axial movement between the first and second inner packer supporting devices (12) and (14).
Patent MX-353794-B (MX)
Title: Connector member.
Inventor: MIYAJIMA NOBUKATSU
IPC: B29C45/26
Filed: 2013-08-15
Abstract: A connector member according to this disclosure includes: a hollow pipe-shaped portion molded by injection molding of a synthetic resin; two ring-shaped seal grooves disposed at an outer peripheral surface of the pipe-shaped portion; and a ring-shaped gate mark formed at a region close to a pipe end with respect to the seal groove, the ring-shaped gate mark being formed at an inner peripheral surface side of the pipe-shaped portion.
Patent MX-348071-B (MX)
Title: Fc variants.
Inventor: GUNASEKARAN KANNAN
IPC: C12P21/02
Filed: 2012-03-15
Abstract: Disclosed are Fc-containing proteins comprising a binding region and a variant Fc region that can elicit one or more immune effector function and/or bind to an Fc receptor more effectively than a similar Fc-containing protein comprising a wild type Fc region. Also disclosed are nucleic acids encoding such Fc-containing proteins, methods for making such proteins, and methods of treatment utilizing such proteins.
Patent MX-360842-B (MX)
Title: Horizontal fracturing tree.
Inventor: KIRK PAUL GUIDRY
IPC: E21B43/26
Filed: 2012-10-10
Abstract: A system 10, in certain embodiments, includes a horizontal fracturing tree 24. The horizontal fracturing tree 24 includes a first hydraulic fracturing bore configured to flow a first fluid, wherein the first hydraulic fracturing bore extends along a first horizontal axis 26, and the first horizontal axis 26 is generally perpendicular to a vertical axis 30 of a wellhead 18.
Patent MX-351702-B (MX)
Title: Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof.
Inventor: MARK D SOLL
IPC: A61K31/7048
Filed: 2013-01-31
Abstract: This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.
Patent MX-358444-B (MX)
Title: Pallet container.
Inventor: DIETMAR PRZYTULLA
IPC: B65D77/04
Filed: 2013-02-19
Abstract: The present invention relates to a pallet container (10) having a thin-walled inner container (12) made of thermoplastic material for storing and transporting liquid or flowable filling materials, having a lattice profile supporting casing (14) that closely encloses the inner container (12) as a supporting casing, and having a base pallet (16) on which the inner container (12) rests and to which the lattice profile supporting casing (14) is firmly connected, wherein the lattice profile supporting casing (14) comprises intersecting vertical (20) and horizontal (22) profile rods which are connected together at their intersecting points by mechanical joining, such as clinching or punch riveting, and wherein the profile rods (20, 22) are additionally fixed in a rotationally secure manner at their connecting points (18, 24, 26) via a mechanical form fit (42, 43) or a form-fitting bearing region (42, 43).
Patent MX-341442-B (MX)
Title: Transmission of control information in a wireless network with carrier aggregation.
Inventor: WANSHI CHEN
IPC: H04L5/00
Filed: 2014-01-24
Abstract: Techniques for sending control information to support operation on multiple component carriers (CCs) are disclosed. A user equipment (UE) may be configured with multiple CCs for carrier aggregation. The multiple CCs may be associated with different uplink-downlink configurations and may have different downlink subframes and uplink subframes. In one aspect, uplink control information (UCI) for a secondary CC (SCC) may be sent on a primary CC (PCC) based on a UCI transmission timeline for the PCC (and not based on a UCI transmission timeline for the SCC). For example, a downlink grant for the SCC may be sent based on a downlink grant transmission timeline for the PCC. In another aspect, uplink grants for an SCC may be sent on the PCC based on an uplink grant transmission timeline for the PCC (and not based on an uplink grant transmission timeline for the SCC).
Patent MX-347921-B (MX)
Title: An apparatus for encoding a speech signal employing acelp in the autocorrelation domain.
Inventor: MULTRUS MARKUS
IPC: G10L19/107
Filed: 2013-07-31
Abstract: An apparatus for encoding a speech signal by determining a codebook vector of a speech coding algorithm is provided. The apparatus comprises a matrix determiner (110) for determining an autocorrelation matrixR, and a codebook vector determiner (120) for determining the codebook vector depending on the autocorrelation matrixR. The matrix determiner (110) is configured to determine the autocorrelation matrix R by determining vector coefficients of a vector r, wherein the autocorrelation matrixR comprises a plurality of rows and a plurality of columns, wherein the vectorr indicates one of the columns or one of the rows of the autocorrelation matrixR, whereinR(i, j) = r(|i- j|), whereinR(i,j) indicates the coefficients of the autocorrelation matrix R, whereini is a first index indicating one of a plurality of rows of the autocorrelation matrixR, and wherein j is a second index indicating one of the plurality of columns of the autocorrelation matrixR.
Patent MX-366493-B (MX)
Title: Compositions and methods for the treatment of brain cancers.
Inventor: STOJDL DAVID
IPC: C12N15/62
Filed: 2012-12-12
Abstract: Described herein is an isolated viral particle having a genome that includes open reading frames that encode: Maraba proteins N, P, and L, or variants thereof; as well as Maraba protein M or protein delta 51M, or variants thereof; and a Bahia Grande G protein, a LCMV G protein, or an Ebola G protein. Maraba protein N may have a sequence which includes SEQ ID NO: 1. Maraba protein P may have a sequence which includes SEQ ID NO: 2. Maraba protein L may have a sequence which includes SEQ ID NO: 3. Maraba proteins M and delta 1M may have sequence which include SEQ ID NO: 4 and 5, respectively. Bahia Grande G protein may have a sequence which includes SEQ ID NO: 6. LCMV G protein may have a sequence which includes SEQ ID NO: 7. Ebola G protein may have a sequence which includes SEQ ID NO: 8.
Patent MX-362356-B (MX)
Title: Method and system for marking an item, an item so marked and a method and system for authenticating a marked item.
Inventor: MYRON SETO
IPC: G06K1/12
Filed: 2013-12-20
Abstract: A method of marking and authenticating a manufactured item, comprising providing the manufactured item with a visible anti-counterfeiting indicium, marking with marking means the manufactured item with a visible alphanumeric string, marking with marking means the manufactured item with visible marking time data, and transmitting with data transmission and control means marking time data marked on the manufactured item and the alphanumeric string marked on the manufactured item. The method further comprises with computer database control means, receiving the transmitted marking time data and the transmitted alphanumeric string and storing in association in a database marking time information corresponding with the received marking time data marked on the manufactured item and alphanumeric information corresponding with the received alphanumeric string marked on the manufactured item. The method further comprises checking authenticity of the anti-counterfeiting indicium provided on the manufactured item, interrogating the database with the alphanumeric string read from the manufactured item to obtain marking time information for the manufactured item, and comparing the marking time information with marking time data read from the manufactured item to determine if they match. The method comprises determining the manufactured item as authentic if criteria are met, the criteria including that the checking step reveals an authentic anti-counterfeiting indicium and the comparing step determines a match.
Patent MX-367049-B (MX)
Title: Cast refiner plate segment with blunt edges and corners for safe handling.
Inventor: YVES RAYMOND
IPC: D21D1/00
Filed: 2014-01-31
Abstract: A cast metal plate segment for a refiner of lignocellulosic material or a disperser of comminuted paper or packaging products, the plate segment including a front side with a front surface configured to refine the lignocellulosic material or disperge the comminuted paper or packaging products, and a back side, opposite to the front side, including a corner or edge, wherein the corner or edge comprises a casted surface between machined planar surfaces adjacent the corner or edge.
Patent MX-365848-B (MX)
Title: Pyridone derivatives for the treatment of viral infections and further diseases.
Inventor: RABOISSON PIERRE JEAN-MARIE BERNARD
IPC: C07D401/06
Filed: 2014-05-23
Abstract: This invention relates to pyridone derivatives, processes for their preparation, phamaceutical compositions, and their use in therapy.
Patent MX-356916-B (MX)
Title: Energy absorbing member.
Inventor: RYAN J MCENEANY
IPC: C08K7/00
Filed: 2014-06-06
Abstract: An energy absorbing member that contains a porous polymeric material is provided. The polymeric material is formed from a thermoplastic composition containing a continuous phase that includes a matrix polymer and within which a microinclusion additive and nanoinclusion additive are dispersed in the form of discrete domains, A porous network is defined in the material that includes a plurality of nanopores having an average cross-sectional dimension of about 800 nanometers or less.